SCHEMBL16894083

SCHEMBL16894083

CC(C)N(CC(=O)O)S(=O)(=O)c1ccc(Cl)s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
ALDH1A1 P00352 5/20 0.39
KMT2A Q03164 3/20 0.39
MAPT P10636 2/20 0.39
TBXA2R P21731 1/20 0.39
PTGDR Q13258 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.39
MMP8 P22894 3/20 0.37
MMP12 P39900 2/20 0.37
MMP13 P45452 2/20 0.37
MMP2 P08253 2/20 0.37
MMP9 P14780 2/20 0.37
MEN1 O00255 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PSEN1 P49768 2/20 0.36
PSEN2 P49810 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16004949 0.75 PSEN1 (0.39) NPC1ALDH1A1KMT2AMAPTTBXA2R
SCHEMBL1287372 0.73 RAB9A (0.48) ALDH1A1MAPTSMN1; SMN2TSHRPSEN1
SCHEMBL264305 0.73 NPC1 (0.42) NPC1ALDH1A1KMT2AMAPTTBXA2R
SCHEMBL1674789 0.72 SLC6A2 (0.41) NPC1ALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL5297763 0.71 MMP2 (0.57) KMT2AMAPTMMP8MMP13MMP2
SCHEMBL1168466 0.70 TBXA2R (0.41) NPC1ALDH1A1KMT2AMAPTTBXA2R
SCHEMBL16016242 0.70 PSEN1 (0.39) NPC1ALDH1A1KMT2AMAPTMEN1
SCHEMBL1287977 0.69 PSEN1 (0.52) KMT2AMEN1PSEN1PSEN2APH1B
SCHEMBL16004831 0.69 NPC1 (0.39) NPC1ALDH1A1KMT2AMAPTTBXA2R
SCHEMBL16894151 0.69 SMN1; SMN2 (0.60) ALDH1A1KMT2AMAPTMMP8MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900642-B1 SUBSTITUTED SULFONAMIDE COMPOUNDS HOFFMANN LA ROCHE (CH) 2018-02-28 EP disclosed
US-9580411-B2 Substituted sulfonamide compounds HOFFMANN-LA ROCHE INC. (US) 2017-02-28 US disclosed
EP-2900642-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS F. Hoffmann-La Roche AG (CH) 2015-08-05 EP disclosed
US-20150197509-A1 SUBSTITUTED SULFONAMIDE SOLUTIONS GENENTECH, INC. (US) 2015-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150197509-A1 SUBSTITUTED SULFONAMIDE SOLUTIONS TRPA1, TRPV1, TRPV5 NPC1 1733/4885ALDH1A1 949/4885KMT2A 2838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.